# Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects

> **NCT01489345** · PHASE1 · COMPLETED · sponsor: **Ono Pharma USA Inc** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ONO-2952
- **DRUG:** ONO-2952 Matching Placebo

## Key facts

- **NCT ID:** NCT01489345
- **Lead sponsor:** Ono Pharma USA Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-04
- **Final completion:** —
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489345, "Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01489345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*